INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 65 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2016. The put-call ratio across all filers is 4.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $237,000 | -3.7% | 58,398 | 0.0% | 0.00% | – |
| Q4 2016 | $246,000 | -38.2% | 58,398 | 0.0% | 0.00% | – |
| Q3 2016 | $398,000 | +17.8% | 58,398 | 0.0% | 0.00% | – |
| Q2 2016 | $338,000 | +29.0% | 58,398 | +55.7% | 0.00% | – |
| Q1 2016 | $262,000 | -3.0% | 37,498 | 0.0% | 0.00% | – |
| Q4 2015 | $270,000 | -16.7% | 37,498 | 0.0% | 0.00% | – |
| Q3 2015 | $324,000 | -46.5% | 37,498 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $606,000 | – | 37,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|